In TCGA patients with CRC, Oxa1 was 88% accurate in identifying N2 patients (95% accurate for sensitive N2 patients [n = 19], and 67% accurate for relapsed N2 patients [n = 6]). The gene discussed is OXA1L; the disease is colorectal carcinoma.